STACEY HAYWARD: Open Payments
NPI 1508552787 · UNIONTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,191 in 63 payments from 9 companies in 2025. Trend: 2023 $541 · 2024 $787 · 2025 $1,191
Food & beverage: $1,164Education: $27
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 12 | $264 |
| Vanda Pharmaceuticals Inc. | 11 | $210 |
| Teva Pharmaceuticals USA, Inc. | 12 | $205 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $171 |
| Otsuka America Pharmaceutical, Inc. | 8 | $149 |
| E.R. Squibb & Sons, L.L.C. | 4 | $85 |
| Neurocrine BioSciences, Inc. | 4 | $71 |
| Lundbeck LLC | 1 | $20 |
| Almatica Pharma LLC | 1 | $14 |
Products named: UZEDY, CAPLYTA, INVEGA SUSTENNA, FANAPT, ABILIFY ASIMTUFII, SPRAVATO, HETLIOZ, COBENFY.
Industry payments across PA — which companies pay providers there.
